Expert US stock short interest and short squeeze potential analysis for identifying high-risk high-reward opportunities in the market. Our short interest data helps you understand bearish sentiment and potential catalysts for short covering rallies that can generate significant returns. We provide short interest data, days to cover analysis, and squeeze potential indicators for comprehensive coverage. Find short opportunities with our comprehensive short interest analysis and potential squeeze indicators for tactical trading.
Tempest Therapeutics Inc. (TPST), a clinical-stage oncology biotech firm, has seen notable price action in recent trading, with shares currently priced at $1.79, representing a 13.29% gain from prior closing levels. This analysis explores recent market context, key technical levels, and potential near-term scenarios for the stock, with no investment recommendations included. The recent uptick in TPST’s share price comes amid a broader shift in small-cap biotech trading sentiment, as investors re
Can Tempest Therapeutics (TPST) Stock Maintain Growth | Price at $1.79, Up 13.29% - Community Chart Signals
TPST - Stock Analysis
4830 Comments
570 Likes
1
Hallel
Influential Reader
2 hours ago
Anyone else want to talk about this?
👍 274
Reply
2
Allina
Trusted Reader
5 hours ago
The technical and fundamental points complement each other nicely.
👍 14
Reply
3
Namaya
Experienced Member
1 day ago
Free US stock comparative valuation tools and peer analysis to identify mispriced securities in the market. We help you understand relative value across different metrics and time periods to find the best opportunities.
👍 95
Reply
4
Keara
Power User
1 day ago
I feel like I was just a bit too slow.
👍 138
Reply
5
Juwayria
Expert Member
2 days ago
I understood it emotionally, not logically.
👍 83
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.